Economic evaluation of pharmaceuticals: science or marketing?

Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands.

Vaccine·2009

Economic evaluation.

Singapore medical journal·2006

Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?

Medical decision making : an international journal of the Society for Medical Decision Making·2005

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Health technology assessment (Winchester, England)·2004

The use of health economic information by reimbursement authorities.

Rheumatology (Oxford, England)·2003

A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

PharmacoEconomics·2026

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

PharmacoEconomics·2026

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

PharmacoEconomics·2026

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

PharmacoEconomics·2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

PharmacoEconomics·2026

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

PharmacoEconomics·2026

[THE PHARMACEUTICAL HUMANITIES IN RUSSIA AND FOR RUSSIA].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry.

Acta medica Philippina·2026

[The Role of Pharmaceutical Universities in Strengthening Japan's Drug Discovery Capabilities: A Pharmaceutical Industry Perspective].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

A randomized, open-label, three-period, cross-over, single intravenous or intramuscular dose, pharmacokinetics and bioequivalence study of vitamin K1 in healthy adults.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Academic Influence and Industry Funding in Platelet-Rich Plasma Injections: Coauthorship Network Analysis.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026

Rupturing the Temporality of Pharmaceutical Patents: A Sketch for a New Temporal Economy of Pharmaceutical Markets.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025

Related Experiment Videos

Economic evaluation of pharmaceuticals: science or marketing?

Related Concept Videos

Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands.

Economic evaluation.

Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?

Generalisability in economic evaluation studies in healthcare: a review and case studies.

The use of health economic information by reimbursement authorities.

A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK.

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

[THE PHARMACEUTICAL HUMANITIES IN RUSSIA AND FOR RUSSIA].

Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry.

[The Role of Pharmaceutical Universities in Strengthening Japan's Drug Discovery Capabilities: A Pharmaceutical Industry Perspective].

A randomized, open-label, three-period, cross-over, single intravenous or intramuscular dose, pharmacokinetics and bioequivalence study of vitamin K1 in healthy adults.

Academic Influence and Industry Funding in Platelet-Rich Plasma Injections: Coauthorship Network Analysis.

Rupturing the Temporality of Pharmaceutical Patents: A Sketch for a New Temporal Economy of Pharmaceutical Markets.

Related Experiment Videos

Economic evaluation of pharmaceuticals: science or marketing?

Related Concept Videos

Related Articles